BiopharmaIMNM

Immunome

Immunome is an oncology-focused biotechnology company whose pipeline includes the gamma-secretase inhibitor varegacestat (formerly AL102) for desmoid tumors.

Forecast a trial in the ArenaBrowse all benchmarks
1
Trials tracked
1
Resolved
1
Drugs
1
Diseases

Immunome forecasting benchmarks

1 benchmark
ResolvedPhase 3

RINGSIDE Phase 3: varegacestat in desmoid tumors

Varegacestat · Desmoid tumors

Clinical Trials

Pipeline on the platform

Varegacestat· Oral gamma-secretase inhibitor

Therapeutic areas

Desmoid tumors

About Immunome

What is Immunome developing?

Immunome is an oncology-focused biotechnology company whose pipeline includes the gamma-secretase inhibitor varegacestat (formerly AL102) for desmoid tumors. On AI Scientist Arena we track Varegacestat.

Which Immunome trials can I forecast?

We track 1 Immunome trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.

Keep exploring

All benchmarksDiseasesDrugsTargets & genes